Most recent update: Thursday, February 14, 2019 - 14:58

Bariatric News - Cookies & privacy policy

You are here


EndoGastric Solutions introduces EsophyX Z+ device for TIF

EsophyX Z+ model device used in TIF 2.0 procedure rebuilding gastroesophageal valve with 270º wrap and 3cm length
The new EsophyX Z+ device supports TIF 2.0 procedure with feature set of EsophyX Z device and benefits of adult sized endoscopes

EndoGastric Solutions has introduced the EsophyX Z+ device that offers expanded endoscope compatibility and joins the company’s portfolio of specialised technologies used to perform the Transoral Incisionless Fundoplication (TIF) 2.0 procedure to reconstruct the gastroesophageal valve and restore its function as a reflux barrier.

Using a transoral approach, the EsophyX Z+ device enables physicians to rebuild the gastroesophageal valve with a partial fundoplication technique that secures the tissue with dual deployment of SerosaFuse® Implantable Fasteners.

“GERD is a chronic condition and proton pump inhibitors do not control symptoms in about one-third of patients,” said Dr Michael Murray, Northern Nevada Medical Center, the first to perform the TIF 2.0 procedure using the new EsophyX Z+ device. “The design of the new EsophyX Z+ device makes performing TIF 2.0 procedures technically easy and produces a consistent and effective fundoplication thus providing an effective alternative to prescription medications and traditional surgical procedures.”

EsophyX Z+ model device with close up of tissue mold showing dual fastener deployment

The evolving EsophyX Z+ technology now enables surgeons and gastroenterologists to use a wider selection of standard endoscopes to treat the underlying anatomical cause of GERD.

“The robust collection of clinical data and recent positive policy coverage announcements support the TIF 2.0 procedure as an established treatment option for patients who wish to eliminate or discontinue PPI use and avoid surgery for acid reflux. This newest design iteration allows for maximal visibility using a standard endoscope combined with almost effortless and confident deployment of fasteners. GI endoscopists and surgeons should consider the TIF procedure in patients seeking a less invasive, proven GERD treatment solution,” said Dr Kenneth Chang, UC Irvine Health.

Performed without the need for external incisions through the skin, the TIF procedure offers patients who require an anatomical repair an effective treatment option to correct the underlying cause of GERD. Most patients stopped using daily medications to control symptoms and had their oesophageal inflammation (esophagitis) eliminated up to three years after the TIF procedure based on studies. mThe EsophyX technology is used to reconstruct the gastroesophageal valve (GEV) and restore its function as a barrier, preventing stomach acids refluxing back into the oesophagus.

“We are excited to launch the EsophyX Z+ device as we believe it will further enhance the physician’s technical experience,” said Skip Baldino, President and CEO of EndoGastric Solutions. “At EndoGastric Solutions, we are committed to addressing the unmet needs in gastrointestinal diseases and offering physicians highly effective options that fill the significant treatment gap between medication and more invasive surgery.”

Want more stories like this? Subscribe to Bariatric News!

Bariatric News
Keep up to date! Get the latest news in your inbox. NOTE: Bariatric News WILL NOT pass on your details to 3rd parties. However, you may receive ‘marketing emails’ sent by us on behalf of 3rd parties.